Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Nakahashi-Ouchida R"'
Autor:
Yuki Y; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; R&D department, HanaVax Inc., Chiba, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Kurokawa S; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Sugiura K; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Kashima K; Technical Research Institute, Asahi Kogyosha Co., Ltd., Tokyo, Japan., Maruyama S; Technical Research Institute, Asahi Kogyosha Co., Ltd., Tokyo, Japan., Yamanoue T; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Honma A; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Mejima M; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Takeyama N; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Research Department, Nisseiken Co., Ltd., Tokyo, Japan., Kuroda M; Division of Genome Editing Research, National Agriculture and Food Research Organization, Tsukuba, Japan., Kozuka-Hata H; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Oyama M; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Masumura T; Laboratory of Genetic Engineering, Graduate School of Agriculture, Kyoto Prefectural University, Kyoto, Japan., Nakahashi-Ouchida R; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan., Fujihashi K; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan.; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, United States., Hiraizumi T; Technical Research Institute, Asahi Kogyosha Co., Ltd., Tokyo, Japan., Goto E; Graduate School of Horticulture, Chiba University, Chiba, Japan., Kiyono H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; R&D department, HanaVax Inc., Chiba, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Research Institute of Disaster Medicine, Chiba University Future Medicine Education and Research Organization, Chiba University, Chiba, Japan.; CU-UCSD Center for Mucosal Immunology, Allergy, and Vaccine (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, San Diego, CA, United States.
Publikováno v:
Frontiers in plant science [Front Plant Sci] 2024 Mar 15; Vol. 15, pp. 1342662. Date of Electronic Publication: 2024 Mar 15 (Print Publication: 2024).
Autor:
Zhang Z; Department of Innovative Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.; Chiba University Futuristic Mucosal Vaccine Research and Development Synergy Institute (cSIMVa), Chiba, Japan., Tanaka I; Department of Innovative Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.; Chiba University Futuristic Mucosal Vaccine Research and Development Synergy Institute (cSIMVa), Chiba, Japan., Nakahashi-Ouchida R; Chiba University Futuristic Mucosal Vaccine Research and Development Synergy Institute (cSIMVa), Chiba, Japan.; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Ernst PB; Department of Medicine, School of Medicine, Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), San Diego, CA, USA.; Division of Comparative Pathology and Medicine, Department of Pathology, University of California, San Diego, CA, USA.; Center for Veterinary Sciences and Comparative Medicine, University of California, San Diego, CA, USA.; Future Medicine Education and Research Organization, Chiba University, Chiba, Japan., Kiyono H; Chiba University Futuristic Mucosal Vaccine Research and Development Synergy Institute (cSIMVa), Chiba, Japan.; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Department of Medicine, School of Medicine, Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), San Diego, CA, USA.; Future Medicine Education and Research Organization, Chiba University, Chiba, Japan.; HanaVax Inc., Tokyo, Japan.; Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Chiba University, Chiba, Japan., Kurashima Y; Department of Innovative Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan. yosukek@chiba-u.jp.; Chiba University Futuristic Mucosal Vaccine Research and Development Synergy Institute (cSIMVa), Chiba, Japan. yosukek@chiba-u.jp.; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. yosukek@chiba-u.jp.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan. yosukek@chiba-u.jp.; Department of Medicine, School of Medicine, Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), San Diego, CA, USA. yosukek@chiba-u.jp.; Division of Clinical Vaccinology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. yosukek@chiba-u.jp.; Institute for Advanced Academic Research, Chiba University, Chiba, Japan. yosukek@chiba-u.jp.
Publikováno v:
Seminars in immunopathology [Semin Immunopathol] 2024 Jan; Vol. 45 (4-6), pp. 549-550.
Autor:
Zhang Z; Department of Innovative Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.; Chiba University Futuristic Mucosal Vaccine Research and Development Synergy Institute (cSIMVa), Chiba, Japan., Tanaka I; Department of Innovative Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan.; Chiba University Futuristic Mucosal Vaccine Research and Development Synergy Institute (cSIMVa), Chiba, Japan., Nakahashi-Ouchida R; Chiba University Futuristic Mucosal Vaccine Research and Development Synergy Institute (cSIMVa), Chiba, Japan.; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Ernst PB; Department of Medicine, School of Medicine, Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), San Diego, CA, USA.; Division of Comparative Pathology and Medicine, Department of Pathology, University of California, San Diego, CA, USA.; Center for Veterinary Sciences and Comparative Medicine, University of California, San Diego, CA, USA.; Future Medicine Education and Research Organization, Chiba University, Chiba, Japan., Kiyono H; Chiba University Futuristic Mucosal Vaccine Research and Development Synergy Institute (cSIMVa), Chiba, Japan.; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Department of Medicine, School of Medicine, Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), San Diego, CA, USA.; Future Medicine Education and Research Organization, Chiba University, Chiba, Japan.; HanaVax Inc., Tokyo, Japan.; Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Chiba University, Chiba, Japan., Kurashima Y; Department of Innovative Medicine, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan. yosukek@chiba-u.jp.; Chiba University Futuristic Mucosal Vaccine Research and Development Synergy Institute (cSIMVa), Chiba, Japan. yosukek@chiba-u.jp.; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. yosukek@chiba-u.jp.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan. yosukek@chiba-u.jp.; Department of Medicine, School of Medicine, Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), San Diego, CA, USA. yosukek@chiba-u.jp.; Division of Clinical Vaccinology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. yosukek@chiba-u.jp.; Institute for Advanced Academic Research, Chiba University, Chiba, Japan. yosukek@chiba-u.jp.
Publikováno v:
Seminars in immunopathology [Semin Immunopathol] 2024 Jan; Vol. 45 (4-6), pp. 493-507. Date of Electronic Publication: 2024 Jan 03.
Autor:
Yuki Y; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; HanaVax Inc, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan. Electronic address: yukiy@ims.u-tokyo.ac.jp., Harada N; Central Research Laboratory, Hamamatsu Photonics K.K, Shizuoka, Japan., Sawada SI; Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan., Uchida Y; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Nakahashi-Ouchida R; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan., Mori H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Yamanoue T; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Machita T; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Kanazawa M; Central Research Laboratory, Hamamatsu Photonics K.K, Shizuoka, Japan., Fukumoto D; Central Research Laboratory, Hamamatsu Photonics K.K, Shizuoka, Japan., Ohba H; Central Research Laboratory, Hamamatsu Photonics K.K, Shizuoka, Japan., Miyazaki T; Toko Yakuhin Kogyo Co., Ltd, Japan., Akiyoshi K; Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan., Fujihashi K; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, USA., Kiyono H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; HanaVax Inc, Tokyo, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan; Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Future Medicine Education and Research Organization, Chiba University, Chiba, Japan; CU-UCSD Center for Mucosal Immunology, Allergy, and Vaccine (cMAV) Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA.
Publikováno v:
Vaccine [Vaccine] 2023 Jul 31; Vol. 41 (34), pp. 4941-4949. Date of Electronic Publication: 2023 Jun 27.
Autor:
Umemoto S; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Otorhinolaryngology & Head and Neck Surgery, Faculty of Medicine, Oita University, Oita, Japan.; Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA., Nakahashi-Ouchida R; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan., Yuki Y; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; HanaVax Inc, Tokyo, Japan., Kurokawa S; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Machita T; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Uchida Y; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Mori H; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Yamanoue T; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Shibata T; Department of Microbiology, Tokyo Medical University, Tokyo, Japan.; Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan., Sawada SI; Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan., Ishige K; Biochemicals Division, Yamasa Corporation, Chiba, Japan., Hirano T; Department of Otorhinolaryngology & Head and Neck Surgery, Faculty of Medicine, Oita University, Oita, Japan., Fujihashi K; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, USA., Akiyoshi K; Department of Polymer Chemistry, Graduate School of Engineering, Kyoto University, Kyoto, Japan., Kurashima Y; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan.; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Institute for Advanced Academic Research, Chiba University, Chiba, Japan.; Department of Innovative Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan., Tokuhara D; Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA.; Department of Pediatrics, Wakayama Medical University, Wakayama, Japan., Ernst PB; Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA.; Division of Comparative Pathology and Medicine, Department of Pathology, University of California, San Diego, CA, USA.; Center for Veterinary Sciences and Comparative Medicine, University of California, San Diego, CA, USA.; Future Medicine Education and Research Organization, Chiba University, Chiba, Japan., Suzuki M; Department of Otorhinolaryngology & Head and Neck Surgery, Faculty of Medicine, Oita University, Oita, Japan., Kiyono H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. kiyono@ims.u-tokyo.ac.jp.; Chiba University-University of California San Diego Center for Mucosal Immunology, Allergy and Vaccine (CU-UCSD cMAV), Department of Medicine, School of Medicine, San Diego, CA, USA. kiyono@ims.u-tokyo.ac.jp.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan. kiyono@ims.u-tokyo.ac.jp.; Chiba University Synergy Institute for Futuristic Mucosal Vaccine Research and Development, Chiba University, Chiba, Japan. kiyono@ims.u-tokyo.ac.jp.; HanaVax Inc, Tokyo, Japan. kiyono@ims.u-tokyo.ac.jp.; Future Medicine Education and Research Organization, Chiba University, Chiba, Japan. kiyono@ims.u-tokyo.ac.jp.; Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Chiba University, Chiba, Japan. kiyono@ims.u-tokyo.ac.jp.
Publikováno v:
NPJ vaccines [NPJ Vaccines] 2023 Jul 24; Vol. 8 (1), pp. 106. Date of Electronic Publication: 2023 Jul 24.
Autor:
Nakahashi-Ouchida R; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan., Fujihashi K; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, USA., Kurashima Y; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan; Division of Mucosal Vaccines, International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Innovative Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan; Institute for Advanced Academic Research, Chiba University, Chiba, Japan; Chiba University-University of California San Diego (CU-UCSD) Center for Mucosal Immunology, Allergy, and Vaccines (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA., Yuki Y; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; HanaVax Inc., Tokyo, Japan., Kiyono H; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan; Future Mucosal Vaccine Research and Development Synergy Institute, Chiba University, Chiba, Japan; Institute for Advanced Academic Research, Chiba University, Chiba, Japan; Chiba University-University of California San Diego (CU-UCSD) Center for Mucosal Immunology, Allergy, and Vaccines (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, USA; Future Medicine Education and Research Organization, Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Chiba University, Chiba, Japan. Electronic address: hkiyono@chiba-u.jp.
Publikováno v:
Trends in molecular medicine [Trends Mol Med] 2023 Feb; Vol. 29 (2), pp. 124-140. Date of Electronic Publication: 2022 Nov 23.
Autor:
Nakahashi-Ouchida R; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Mori H; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Yuki Y; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; HanaVax Inc., Tokyo, Japan., Umemoto S; Faculty of Medicine, Department of Otorhinolaryngology, Head and Neck Surgery, Oita University, Oita, Japan.; CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, San Diego, CA, United States., Hirano T; Faculty of Medicine, Department of Otorhinolaryngology, Head and Neck Surgery, Oita University, Oita, Japan., Uchida Y; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Machita T; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Yamanoue T; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan., Sawada SI; Department of Polymer Chemistry, Faculty of Engineering, Kyoto University, Kyoto, Japan., Suzuki M; Faculty of Medicine, Department of Otorhinolaryngology, Head and Neck Surgery, Oita University, Oita, Japan., Fujihashi K; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; Division of Clinical Vaccinology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, United States., Akiyoshi K; Department of Polymer Chemistry, Faculty of Engineering, Kyoto University, Kyoto, Japan., Kurono Y; Department of Otolaryngology, Faculty of Medicine, Kagoshima University, Kagoshima, Japan., Kiyono H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Human Mucosal Vaccinology, Chiba University Hospital, Chiba, Japan.; HanaVax Inc., Tokyo, Japan.; CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), Division of Gastroenterology, Department of Medicine, University of California, San Diego, San Diego, CA, United States.; Future Medicine Education and Research Organization, Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Chiba University, Chiba, Japan.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Jul 06; Vol. 13, pp. 819859. Date of Electronic Publication: 2022 Jul 06 (Print Publication: 2022).
Autor:
Yuki Y; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan., Nojima M; Center for Translational Research, IMSUT Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan., Kashima K; Asahi Kogyosha Co., Ltd., Tokyo, 105-0013, Japan., Sugiura K; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan., Maruyama S; Asahi Kogyosha Co., Ltd., Tokyo, 105-0013, Japan., Kurokawa S; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan., Yamanoue T; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan., Nakahashi-Ouchida R; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccine, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan., Nakajima H; Asahi Kogyosha Co., Ltd., Tokyo, 105-0013, Japan., Hiraizumi T; Asahi Kogyosha Co., Ltd., Tokyo, 105-0013, Japan., Kohno H; Asahi Kogyosha Co., Ltd., Tokyo, 105-0013, Japan., Goto E; Graduate School of Horticulture, Chiba University, Chiba, Japan., Fujihashi K; Division of Clinical Vaccinology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL 35294-0007, USA., Kiyono H; Department of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan; Division of Mucosal Vaccines, International Research and Development Center for Mucosal Vaccine, The Institute of Medical Science, The University of Tokyo, Tokyo, 108-8639, Japan; Mucosal Immunology and Allergy Therapeutics, Institute for Global Prominent Research, Future Medicine Education and Research Organization, Chiba University, Chiba, 263-8522, Japan; CU-UCSD Center for Mucosal Immunology, Allergy, and Vaccine (cMAV) Division of Gastroenterology, Department of Medicine, University of California, San Diego, CA, 92093-0956, USA. Electronic address: kiyono@ims.u-tokyo.ac.jp.
Publikováno v:
Vaccine [Vaccine] 2022 May 26; Vol. 40 (24), pp. 3372-3379. Date of Electronic Publication: 2022 Apr 26.
Autor:
Kiyono H; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Medicine, School of Medicine and CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines, University of California, San Diego, San Diego, CA, USA., Yuki Y; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Nakahashi-Ouchida R; Division of Mucosal Immunology, IMSUT Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Fujihashi K; Division of Clinical Vaccinology, International Research and Development Center for Mucosal Vaccines, Institute of Medical Science, University of Tokyo, Tokyo, Japan.; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, USA.
Publikováno v:
International immunology [Int Immunol] 2021 Nov 25; Vol. 33 (12), pp. 767-774.
Autor:
Yuki Y; Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Nojima M; Center for Translational Research, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Hosono O; Division of Rheumatology, Center for Antibody and Vaccine Therapy, Department of Allergy and Rheumatology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Tanaka H; Division of Rheumatology, Center for Antibody and Vaccine Therapy, Department of Allergy and Rheumatology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Kimura Y; Division of Systems Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Satoh T; Division of Systems Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Imoto S; Health Intelligence Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Uematsu S; Division of Innate Immune Regulation, International Research and Development Center for Mucosal Vaccines and Division of Metagenome Medicine, Human Genetic Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Immunology and Genomics, Osaka City University Graduate School of Medicine, Osaka, Japan., Kurokawa S; Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Kashima K; Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Asahi Kogyosha, Tokyo, Japan., Mejima M; Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Nakahashi-Ouchida R; Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Uchida Y; Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Marui T; Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Yoshikawa N; Division of Rheumatology, Center for Antibody and Vaccine Therapy, Department of Allergy and Rheumatology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Nagamura F; Division of Advanced Medicine Promotion, Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan., Fujihashi K; Division of Clinical Vaccinology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Pediatric Dentistry, The University of Alabama at Birmingham, Birmingham, AL, USA., Kiyono H; Division of Mucosal Immunology, International Research and Development Center for Mucosal Vaccines, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Distinguished Professor Unit, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan; Department of Medicine, School of Medicine and CU-UCSD Center for Mucosal Immunology, Allergy and Vaccine, University of California, San Diego, San Diego, CA, USA. Electronic address: kiyono@ims.u-tokyo.ac.jp.
Publikováno v:
The Lancet. Microbe [Lancet Microbe] 2021 Sep; Vol. 2 (9), pp. e429-e440. Date of Electronic Publication: 2021 Jun 25.